baber/WOPTO huggingface dataset:
Patent CA-3080095-A1 (CA)
Inventor: BEATTIE WILLIAM D
IPC: F03B17/06
Filed: 2020-04-30
Abstract: A subaqueous hydrokinetic electric energy system includes a stator including a first plurality of electricity-generating elements. The system also includes a rotor including a second plurality of electricity-generating elements. The rotor is disposed radially outward of an outer circumferential surface of the stator and is configured to rotate around the stator about an axis of rotation. The rotor is a cylindrical structure having a variable ovoid structure attached fore and aft and extending along a portion of an axial length of the stator. The system further includes at least two hydrodynamic bearing mechanisms configured to support the rotor relative to the stator during rotation of the rotor around the stator.
Patent CA-3083685-A1 (CA)
Title: Composition d'implantation sechee et formulation d'implantation aqueuse injectable
Inventor: SUPPIGER DANIEL
IPC: A61L27/46
Filed: 2018-12-14
Abstract: L'invention concerne : une composition d'implantation séchée se composant essentiellement d'un mélange de particules d'hydroxyapatite nanocristalline issues d'os naturel ayant une taille de 50 à 200 µm et de fragments de matière collagène fibreuse naturellement réticulée qui passent à travers un crible de 0,5 mm, le rapport poids/poids de l'hydroxyapatite au collagène valant de 1,8 à 4,5; l'utilisation de cette composition d'implantation séchée pour préparer une formulation d'implantation aqueuse injectable destinée à être utilisée dans la régénération des tissus buccaux, qui peut être extrudée par l'intermédiaire d'un système à diamètre décroissant et d'une canule calibre 18 (0,838 mm de diamètre intérieur) de longueur 25,4 mm; une formulation d'implantation aqueuse injectable destinée à être utilisée dans la régénération des tissus buccaux, la formulation d'implantation aqueuse injectable pouvant être obtenue par réhydratation et mélange homogène de 25 à 45 % en poids de la composition d'implantation séchée mentionnée ci-dessus avec de l'eau stérile ou une solution saline isotonique stérile, laquelle peut être extrudée par l'intermédiaire d'un système à diamètre décroissant et d'une cannule calibre 18 (0,838 mm de diamètre intérieur) de longueur 25,4 mm avec une force ne dépassant pas 60 N; un procédé de préparation de la formulation d'implantation aqueuse injectable mentionnée ci-dessus comprenant une réhydratation et un mélange homogène de 25-45 % en poids d'une composition d'implantation sèche telle que définie ci-dessus dans de l'eau stérile ou une solution saline isotonique stérile; un kit pour préparer la formulation d'implantation aqueuse injectable mentionnée ci-dessus destinée à être utilisée dans la régénération de tissus buccaux, le kit comprenant une seringue équipée d'un dispositif de mélange qui contient une composition d'implantation séchée telle que définie ci-dessus, un système à diamètre décroissant et une canule calibre 18 (0,838 mm de diamètre intérieur) de longueur 25,4 mm, un récipient rempli d'une quantité appropriée d'eau stérile ou d'une solution isotonique stérile.
Patent CA-3084237-A1 (CA)
Inventor: HAMPEL THOMAS
IPC: B27M1/08
Filed: 2018-11-02
Abstract: L'invention concerne une installation de traitement de chants, comprenant au moins une machine de traitement de chants (1, 40), sur laquelle est monté un magasin de chants (10), et au moins un réservoir de cassettes principal (2) agencé à proximité dans l'espace du magasin de chants (10) de la machine de traitement de chants (1, 40). Le réservoir de cassettes principal (2) comprend une pluralité d'emplacements de logement (21, 22) dans lesquels peuvent être logées ou sont logées des cassettes (6) contenant respectivement une alaise de chants (5). L'installation de traitement de chants comporte en outre au moins un réservoir de cassettes secondaire (4, 8, 50) qui diffère du réservoir de cassettes principal (2), et qui est agencé de façon à être séparé dans l'espace du réservoir de cassettes principal (2).
Patent CA-3084984-A1 (CA)
Title: Compounds for the degradation of stk4 and treatment of hematologic malignancies
Inventor: BUHRLAGE SARA
IPC: C07D401/14
Filed: 2018-12-13
Abstract: The application relates to a compound of Formula (I) which modulate the amount of STK4, a pharmaceutical composition comprising the compound, and a method of treating or preventing a disease or disorder associated with the modulation of STK4.
Patent CA-3085611-A1 (CA)
Title: A method for autonomously controlling a vehicle
Inventor: WHITFIELD JAMES
IPC: G05D1/02
Filed: 2020-07-03
Abstract: The present application provides a method for autonomously controlling a vehicle performed by a control system of the vehicle on the basis of a mission received from a mission controller, the method comprising: - receiving a mission comprising a set of instructions from the mission controller; - validating the mission by checking whether the mission meets a first set of requirements; - executing the mission if the mission meets the first set of requirements and - rejecting the mission if the mission does not meet the first set of requirements.
Patent CA-3086500-A1 (CA)
Title: Methods, systems and apparatuses for management and storage
Inventor: ALDER DEBORAH
IPC: G16H20/10
Filed: 2011-12-08
Abstract: 86838004 ABSTRACT The present invention relates to systems, methods, and apparatuses for the management, distribution, dispensing, and administration of consumer products, including over-the-counter and prescription medications through use of a product container labeling system and an optional integrated computer-based or online management system. In certain aspects, the invention relates to a product container comprising a hollow body, a child-resistant cap, and a specialized information label affixed to the hollow body. Date Recue/Date Received 2020-07-10
Patent CA-3089276-A1 (CA)
Inventor: LI ZHEN
IPC: C12N15/113
Filed: 2019-02-15
Abstract: L'invention concerne des agents de liaison améliorés qui sont utiles pour faciliter la fixation de groupes de ciblage, d'activateurs ou de modificateurs pharmacocinétiques (PK), ou d'autres agents d'administration à des oligonucléotides. Les agents de liaison décrits peuvent présenter des rendements de réaction, une stabilité et une activité biologique améliorés, en particulier lorsqu'ils sont Utilisés en association avec des composés à base d'oligonucléotides, tels que des agents d'ARN interférence (ARNi).
Patent CA-3089752-A1 (CA)
Title: System, computing device, and method for mapping an activity of a player in a non-virtual environment into a virtual environment
Inventor: GUILLEMETTE JONATHAN
IPC: A63B71/00
Filed: 2019-01-29
Abstract: A system and method for mapping a play activity performed by a player in a non-virtual environment into a virtual gaming environment are provided. At least one data collector is configured to collect, at least during the play activity, data indicative of a performance of the player. A computing device obtains, from the at least one data collector, the data indicative of the performance of the player and updates, based on the obtained data, one or more characteristics associated with a virtual representation of the player within a virtual environment of a virtual game.
Patent CA-3091658-A1 (CA)
Inventor: ASAKA SAORI
IPC: H04N19/139
Filed: 2009-06-18
Abstract: ABSTRACT The present invention provides a video decoding apparatus that improves degrees of freedom for calculating a motion vector by selecting one from enclosed blocks. The video decoding apparatus comprises processing circuitry configured to: acquire one or more available blocks having a motion vector from decoded blocks adjacent to a to-be-decoded block and a number of the available blocks; select a first block from the available blocks; select a plurality of code words based on the number of the available blocks; and decode selection information specifying the first block from the available blocks using a code table corresponding to the first block from the available blocks, the code table including index and code words corresponding to the index, and the to- be-decoded block by using a motion vector of the first block, wherein a number of the index is determined depending on the number of the available blocks. Date Recue/Date Received 2020-08-31
Patent CA-3093804-A1 (CA)
Inventor: HISAYAMA KAZUSHI
IPC: F25B31/00
Filed: 2019-03-25
Abstract: In refrigeration cycle devices having a double vibration isolation structure, it was problematic that if the compressor was not arranged in a suitable position on a middle platform, swaying of the compressor would increase during vibration, and the compressor would be subject to a large centrifugal force. When the compressor (1) is arranged with interposition of a bottom member (20a) of a frame (20), a second elastic member (24), a platform (21), and a first elastic member (23), said compressor is arranged near the placement center of gravity of the second elastic component (32).
Patent CA-3095676-A1 (CA)
Inventor: SIMARD JOHN
IPC: A61K39/395
Filed: 2020-10-07
Abstract: Fully human monoclonal Abs includes (i) an antigen-binding variable region that exhibits very high binding affinity for IL-la and (ii) a constant region that is effective at both activating the complement system though Clq binding and binding to several different Fc receptors.
Patent CA-3096292-A1 (CA)
Title: Toothbrush head for optimized toothpaste distribution
Inventor: VERONNEAU JACQUES
IPC: A46B9/04
Filed: 2020-10-19
Abstract: The present invention relates to a toothbrush head design with modified bristles for optimal toothpaste efficacy. The modified bristles are specifically designed to accommodate an optimal quantity of toothpaste and comprise a central reduction in the length of the bristles defining either a pea-shaped or rice-shaped cavity, depending on the age of the user. This particular design can be combined to any existing toothbrush and, more particularly, to toothbrush heads with various modified bristles. The present invention will improve toothpaste delivery to dental surfaces and, in particular, difficult-to-reach regions. The present invention provides, for the first time, a clear and simple guideline for health professionals as well as manufacturers for promoting optimal dosage.
Patent CA-3104704-A1 (CA)
Inventor: AYARES DAVID
IPC: C12N5/071
Filed: 2010-08-16
Abstract: ABSTRACT The present invention provides certain animals, and in particular porcine animals, tissue and cells derived from these, which lack any expression of functional alpha 1,3 galactosyltransferase (aGT) and express one or more additional transgenes which make them suitable donors for pancreatic islet xenotransplantation. Methods of treatment and prevention of diabetes using cells derived from such animals are also provided. Date Recue/Date Received 2020-12-30
Patent CA-3109853-A1 (CA)
Inventor: DAVIS NIKOLAS
IPC: F04D13/02
Filed: 2019-06-18
Abstract: An electrical submersible pump assembly (11) for pumping well fluid from a well has a motor (17) and a pump (13). The motor has a motor shaft (77) that drives a pump shaft (25) of the pump. A thrust bearing unit (20) between the motor and the pump has a thrust bearing shaft (29) that rotates a thrust runner (33) in sliding engagement with a non-rotating thrust bearing base (35). A pump shaft coupling (37) couples the thrust bearing shaft with the pump shaft. A motor shaft coupling (81) couples the thrust bearing shaft with the motor shaft. At least one of the couplings has a one-way clutch (48) that allows forward direction rotation of the thrust bearing shaft and prevents reverse direction rotation.
Patent CA-3113788-A1 (CA)
Title: Surgical irrigation cassette
Inventor: FINEOUT BEN
IPC: A61M1/00
Filed: 2019-09-18
Abstract: A surgical irrigation cassette comprises a cassette housing, a portion of a pump, and fluid pathways. The housing defines a chamber therein and a first console connector including a first pneumatic connector port. The pump portion includes an intake side of the pump and an output side of the pump. The fluid pathways are disposed at least in part within the chamber. A first fluid pathway, in an installed position, connects the intake side of the pump with a supply fluid container. A second fluid pathway, in an installed position, connects the output side of the pump and a handpiece. A third fluid pathway, in an installed position, connects the handpiece and a waste container. A fourth fluid pathway, in an installed position, connects the first console connector and the waste container.
Patent CA-3117275-A1 (CA)
Inventor: LANGEDIJK JOHANNES PETRUS MARIA
IPC: C07K14/005
Filed: 2019-11-12
Abstract: The present invention provides stable pre-fusion respiratory syncytial virus (RSV) F proteins, immunogenic compositions comprising said proteins and uses thereof for the prevention and/or treatment of RSV infection.
Patent CA-3120244-A1 (CA)
Title: Signal multiplexer for sonar
Inventor: CORBEL PHILIPPE
IPC: H04L5/06
Filed: 2019-11-15
Abstract: Disclosed is a sonar comprising a first part (201) and a second part (202) connected by an electric carrier cable (203) configured to mechanically support the second part and allow the two parts of the sonar to exchange signals comprising: - a unidirectional signal referred to as a power supply signal (210, 220), - unidirectional signals referred to as signals to be emitted (211, 221), transmitted by the first part to the second part with a view to their emission in the form of acoustic waves, and - a bidirectional signal transporting communication data (212, 222), the sonar being characterised in that the first part comprises means (213) for combining the signals configured such that the signals are transmitted simultaneously on the electric carrier cable, and in that the second part comprises separation means (223) allowing the recovery of each of the signals transmitted on the electric carrier cable.
Patent CA-3122623-A1 (CA)
Inventor: WAN ZHONGHUI
IPC: A61K31/472
Filed: 2020-01-10
Abstract: La présente invention se rapporte au domaine technique de la médecine. Plus particulièrement, la présente invention concerne des composés d'halogénoallylamine tels que représentés par la formule (I) ou des sels, esters, stéréoisomères et tautomères pharmaceutiquement acceptables de ceux-ci, ainsi que des préparations pharmaceutiques et des compositions pharmaceutiques contenant ces composés, et leur utilisation dans la prévention et/ou le traitement de maladies associées ou à médiation par la protéine SSAO/VAP-1, R1, R2, R3, R4, R5, R6, L1 et Cy1 étant définis dans la description.
Patent CA-3123199-A1 (CA)
Title: A method of recycling tires
Inventor: MOLLOY MARK
IPC: B29B17/00
Filed: 2018-12-12
Abstract: A method of recycling tires comprising the comprising the steps of: placing tires and/or pieces of tires within a casing or mold, applying a binder (e.g. adhesives and/or pining with screws, nails, nuts and bolts, pins, wire and steel or nylon bands etc) to the tires and/or pieces of tires so that the tires are bound together; applying a reinforcing means to the tires and/or pieces of tires (e.g. fitting the reinforcing means around, in between and/or through the tires etc); and melting or pouring an encapsulating means over the top of the tires and reinforcing means to encapsulate them inside the casing or mold and the encapsulating means; and causing or allowing the encapsulating means to set such that a recycled product is formed.
Patent CA-3125106-A1 (CA)
Inventor: LEE DONG YUN
IPC: C12Q1/6883
Filed: 2019-12-27
Abstract: La présente invention concerne une composition pour diagnostiquer une maladie associée à Helicobacter pylori et une utilisation correspondante, la composition comprenant une formulation pour mesurer le niveau d'expression d'un gène dont l'expression est augmentée ou diminuée par une infection à Helicobacter pylori.
Patent CA-3127373-A1 (CA)
Title: P38 kinase inhibitors reduce dux4 and downstream gene expression for the treatment of fshd
Inventor: CACACE ANGELA MARIE
IPC: C12N15/63
Filed: 2018-10-05
Abstract: The disclosure relates to methods and compositions including p38 kinase inhibitors and agents that regulate expression of DUX4 and downstream genes including but not restricted to ZSCAN4, LEUTX, PRAMEF2, TRIM43, MBD3L2, KHDC1L, RFPL2, CCNA1, SLC34A2, TPRX1, PRAMEF20, TRIM49, PRAMEF4, PRAME6, PRAMEF15, or ZNF280A. Methods useful for treating a disease associated with abnormal DUX4 and downstream gene expression (e.g., Fascioscapulohumeral muscular dystrophy) are disclosed.
Patent CA-3130191-A1 (CA)
Title: Medical device and method for remotely accessing a medical device
Inventor: JOHANNESSON CAMILLA
IPC: G16H40/67
Filed: 2020-04-16
Abstract: The disclosure relates to the field of medical devices, and more specifically to techniques for remotely accessing automated medical devices. According to a first aspect, the disclosure relates to a method for remotely accessing a medical device (10) configured to perform a medical procedure. The method comprises that the remote communication process (PCOMM ) performs the steps of configuring (S1) at least one access criterion for remotely accessing the medical device and establishing (S2) a secure connection between the medical device and a remote system. The method further comprises that the remote communication process (PCOMM ) performs the steps of receiving (S3) from the remote system, a request to access the one or more medical processes and forwarding (S5a) the request to the one or more medical processes, upon the request fulfilling the configured at least one access criterion for remotely accessing the medical device (10).
Patent CA-3131945-A1 (CA)
Title: A loss of function rodent model of solute carrier 39 member 5
Inventor: NISTALA HARIKIRAN
IPC: G01N33/50
Filed: 2020-03-12
Abstract: This disclosure relates to a rodent model. More specifically, this disclosure relates to a loss of function of solute carrier 39 member 5 (SLC39A5) rodent model. In particular, disclosed herein are genetically modified rodent animals that carry a loss of function mutation in an endogenous Slc39a5 gene and use of such rodent animals in elucidating the role of SLC39A5 in zinc homeostasis, glycemic regulation and lipid metabolism.
Patent CA-3132895-A1 (CA)
Title: Utilisations d'inhibiteurs de la phosphodiesterase
Inventor: SHENG ZEJUAN
IPC: A61K31/55
Filed: 2020-03-06
Abstract: Il est décrit des utilisations d'un composé représenté par la formule générale (I) et de sels, isomères et composés deutérés pharmaceutiquement acceptables de ce dernier dans la préparation d'un médicament pour le traitement de maladies impliquant une insuffisance cardiaque. Des expériences ont montré que le composé pouvait améliorer la fonction cardiaque de rats présentant une insuffisance cardiaque, inverser le remodelage myocardique provoqué par une insuffisance cardiaque, et réduire la fibrose dans la zone marginale d'un infarctus.
Patent CA-3134702-A1 (CA)
Title: Dispositif a cycle frigorifique
Inventor: HISAYAMA KAZUSHI
IPC: F25B1/10
Filed: 2020-03-26
Abstract: L'invention concerne un circuit de fluide frigorigène (20) comprenant : un premier compresseur (21); un second compresseur (22); un échangeur de chaleur (24) côté source de chaleur ; un mécanisme de dilatation (26); et un échangeur de chaleur (27) côté utilisateur. Le circuit de fluide frigorigène (20) est apte à réaliser une opération de compression à un seul étage dans laquelle l'un du premier compresseur (21) et du second compresseur (22) est entraîné et l'autre est arrêté, et une opération de compression à deux étages dans laquelle à la fois le premier compresseur (21) et le second compresseur (22) sont entraînés. Une unité de commande (100) commande le circuit de fluide frigorigène (20) de telle sorte qu'entre l'opération de compression à un seul étage et l'opération de compression en deux étapes, celle qui aura une efficacité de compression la plus élevée soit effectuée.
Patent CA-3135615-A1 (CA)
Title: Inducteurs de la ho-1
Inventor: BIDDLE MARGARET
IPC: C07D513/04
Filed: 2020-04-08
Abstract: La présente invention concerne des composés de structure (I) utilisés comme inducteurs de l'hème oxygénase 1 (HO-1). La présente invention concerne également un procédé permettant de maîtriser l'activité ou la quantité, ou l'activité et la quantité, de l'hème-oxygénase 1 chez un sujet mammifère. Les définitions des variables sont fournies dans la description.
Patent CA-3137018-A1 (CA)
Title: Amantadine binding protein
Inventor: PARK JOOYOUNG
IPC: C07K1/113
Filed: 2020-04-15
Abstract: Disclosed herein are amantadine binding polypeptides, fusion proteins thereof, and uses of such polypeptides and fusion proteins.
Patent CA-3137252-A1 (CA)
Title: Endonasal drug delivery device
Inventor: NARCISO PAOLO
IPC: A61M15/08
Filed: 2020-04-16
Abstract: Endonasal drug delivery device suitable for inhalation comprising a shaped body (2) having a first portion (5) located at a first end (6) of the shaped body (2), shaped to be inserted in a nasal cavity and having an air delivery duct (7), a second intermediate portion (9) having at least one air supply duct (10) for allowing it to flow from the outside to the inside of the endonasal delivery device (1) and a third portion (12) located at the opposite end (13) of the first portion (5) and comprising a mixing chamber (14). The latter being in fluid communication with the supply duct (10), a drug reservoir (3) and the delivery duct (7).
Patent CA-3138298-A1 (CA)
Inventor: COTARI JESSE
IPC: C12N15/86
Filed: 2020-04-30
Abstract: La présente invention concerne, entre autres, des procédés et des systèmes pour préparer des cellules progénitrices oligopotentes et unipotentes de lignées définies en culture à partir d'une source étendue de cellules CD34+ , des milieux pour les préparer, et des composés thérapeutiques et des compositions les comprenant pour le traitement d'une variété de maladies incluant, mais sans s'y limiter, les troubles hématologiques, les maladies immunitaires, les cancers et les maladies infectieuses.
Patent CA-3148633-A1 (CA)
Inventor: CHEN PING
IPC: A24F40/40
Filed: 2020-06-01
Abstract: A mesh-shaped sheet-type porous heating atomization assembly (3) and a heating atomizer therewith. The heating atomization assembly comprises a porous liquid guide body (1) for absorbing and guiding liquid, and a planar sheet-shaped electric heating trajectory (2) arranged inside the porous liquid guide body (1). One or more planar sheet-shaped electric-heating trajectories (2) are provided, and the planar sheet-shaped electric heating trajectory (2) is used for heating the liquid to atomize same. One or more penetrating airflow through holes (11) are provided in the porous liquid guide body (1). The planar sheet-shaped electric heating trajectory (2) is a planar heating mesh composed of one or more heating trajectories connected in parallel. The heating atomizer comprises the mesh-shaped sheet-type porous heating atomization assembly (3). The mesh-shaped sheet-type porous heating atomization assembly (3) and the heating atomizer therewith have the advantages of facilitating mass production, realizing uniform heating and having a large atomization area and a large amount of vapor.
Patent CA-3149336-A1 (CA)
Title: Reinforced hybrid pressure vessel having a plastic liner and metallic boss
Inventor: SONNEN MICHAEL
IPC: F17C1/16
Filed: 2020-08-27
Abstract: The invention relates to a hybrid pressure vessel having a fiber composite component and a metal component. The invention furthermore relates to a method for producing such a hybrid pressure vessel. The hybrid pressure vessel according to the invention has a liner having an inner side and an outer side and having an outside diameter DL and a metal boss having an outside diameter DB, wherein the metal boss is designed to receive a valve, the hybrid pressure vessel having a storage volume in the interior thereof, the liner being tubular and wherein the outside diameter DB of the boss is at least exactly as large as the outside diameter DL of the liner.